Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa)

Journal of Alternative and Complementary Medicine

Volumn 9, Issue 1, 2003, Pages 161-168

  Chainani Wu, Nita ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; COLLAGENASE; CURCUMIN; CYCLOOXYGENASE 2; ELASTASE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HYALURONIDASE; INTERLEUKIN 12; LEUKOTRIENE; LIPOXYGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PHENYLBUTAZONE; PHOSPHOLIPASE; PLACEBO; PROSTAGLANDIN; THROMBOXANE; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; CURCUMA LONGA; DRUG MECHANISM; DRUG SAFETY; ENZYME INHIBITION; GINGER; HUMAN; INDIA; INFLAMMATION; MEDICAL LITERATURE; NONHUMAN; POSTOPERATIVE PAIN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; SPICE; STOMACH DISEASE; TOXICITY; TOXICITY TESTING; VERTIGO;

EID: 0037291286     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/107555303321223035     Document Type: Article

References (46)

1. Ammon H, Safayhi H, Mack T, Sabieraj. Mechanism of antiinflammatory actions of curcumin and boswellic acids. J Ethnopharmacol 1993;38:113.
2. Apisariyakul A, Vanittanakom N, Buddhasukh D. Antifungal activity of tumeric oil extracted from Curcuma longa (Zingiberaceae). J Ethnopharmacol 1995;49:163-169.
3. Began G, Sudharshan E, Appu Rao AG. Inhibition of lipooxygenase 1 (LOX1) by phosphatidylcholine micelles-bound curcumin. Lipids 1998;33:1223-1228.
4. Bisset NG, ed. Herbal Drugs and Phytopharmaceuticals. Boca Raton, FL: CRC Press, 1994.
5. Brouet I, Ohshima H. Curcumin an anti-tumor promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun 1995;206:533-540.
6. Chan MM. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol 1995a;26: 49(11):1551-1556.
7. Chan MM, Ho CT, Huang HI. Effects of three dietary phytochemicals from tea, rosemary and tumeric on inflammation induced nitrite production. Cancer Lett 1995b;96:23-29.
8. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001; 21:2895-2900.
9. Deodhar SD, Sethi R, Srimal RC. Preliminary studies on antirheumatic activity of curcumin. Ind J Med Res 1980;71:632-634.
10. Deshpande SS, Lalitha VS, Ingle AD, Raste AS, Gadre SG, Maru GB. Subchronic oral toxicity of tumeric and ethanolic tumeric extract in female mice and rats. Toxicol Lett 1998;95:183-193.
11. Eigner D, Scholz D. Ferula asa-foetida and Curcuma longa in traditional medical treatment and diet in Nepal. J Ethnopharmacol 1999;67:1-6.
12. Goel A, Boland CR, Chauhan DP. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett 2001;172:111-118.
13. Ireson CR, Jones DJ, Orr S, Coughtrie MW, Boocock DJ, Williams ML, Farmer PB, Steward WP, Gescher AJ. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 2002;11:105-111.
14. James JS. Curcumin trial results: Antiviral effect reported. AIDS Treatment News 198, May 6, 1994. www.aidsinfobbs.org/periodicals/am/1994/198
15. Joe B, Lokesh BR. Effect of curcumin and capsaicin on arachadonic acid metabolism and lysosomal enzyme secretion by rat peritoneal macrophages. Lipids 1997;32:1173-1180.
16. Joe B, Rao UJ, Lokesh BR. Presence of an acidic glycoprotein in the serum of arthritic rats: Modulation by capsaicin and curcumin. Mol Cell biochem 1997;169: 125-134.
17. Kandarkar SV, Sawant SS, Ingle AD, Deshpande SS, Maru GB. Subchronic oral hepatotoxcity of turmeric in micehistopathological and ultrastructural studies. Indian J Exp Biol 1998;36:675-679.
18. Kang BY, Chung SW, Chung W, Im S, Hwang SY, Kim TS, Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. Eur J Pharmacol 1999;384:191-195.
19. Kang BY, Song YJ, Kim KM, Choe YK, Hwang SY, Kim TS. Curcumin inhibits Th1 cytokine profile in CD4+ Tcells by suppressing interleukin-12 production in macrophages. Br J Pharmacol 1999;128:380-384.
20. Lal B, Kapoor AK, Agrawal PK, Asthana OP, Srimal RC. Role of curcumin in Idiopathic Inflammatory orbital pseudotumors. Phytother Res 2000;14:443-447.
21. Lal B, Kapoor AK, Asthana OP, Agrawal PK, Prasad R, Kumar P, Srimal RC. Efficacy of curcumin in the management of chronic anterior uveitis. Phytother Res. 1999;13:318-322.
22. Miller L, Murray WJ. Herbal Medicinals. A Clinician's Guide. Binghamton, NY: Pharmaceutical Products Press, 1998.
23. Muhammed M, Badmaev V, Murray F. Tumeric and the Healing Curcuminoids. A Keats Good Health Guide. New Canaan, CT: Keats Publishing, Inc., 1996.
24. Majeed M, Badmaev V, Shivakumar U, Rajendran R. Curcuminoids. Antioxidant Phytonutrients. Piscataway, NJ: Nutriscience Publishers, Inc., 1995.
25. Nagabhushan M, Bhide SV. Nonmutagenicity of curcumin and its antimutagenic action versus chili and capsaicin. Nutr Cancer 1986;8:201-210.
26. PDR for Herbal Medicines, 2nd ed. Montvale, NJ: Medical Economics Company, Inc., 2000.
27. Peirce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York, NY: The Stonesong Press, Inc., 1999.
28. Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, Farrow S, Howells L. Inhibition of cyclooxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NFKB activation via the NIK/IKK signalling complex. Oncogene 1999;18:6013-6020.
29. Ramsewak RS, DeWitt DL, Nair MG. Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. Phytomedicine 2000;7: 303-308.
30. Ranjan D, Johnston TD, Wu G, Elliott L, Bondada S, Nagabhushan M. Curcumin blocks cyclosporin A-resistant CD28 costimulatory pathway of human T-cell proliferation. J Surg Res 1998;77:174-178.
31. Rao CV, Rivenson A, Simi B, Reddy BS. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occuring plant phenolic compound. Cancer Res 1995;55:259-266.
32. Rasyid A, Lelo A. The effect of curcumin and placebo on human gall-bladder function: An ultrasound study. Aliment Pharmacol Ther 1999;13:245-249.
33. Roth G, Chandra A, Nair M. Novel bioactivities of Curcuma longa constituents J Nat Prod 1998;61:542-545.
34. Ruby J, Kuttan G, Babu KD, Rajashekharan KN, Kuttan R. Antitumor and oxidant activity of natural curcumnoids. Cancer Lett 1995;94:79-83.
35. Satoskar RR, Shah SJ, Shenoy SG. Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int J Clin Pharmacol Ther Toxicol 1986;24:651-654.
36. Shah BH, Nawaz Z, Pertani SA, Roomi A, Mahmood H, Saeed SA, Gilani AH Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor-and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Biochem Pharmacol 1999;58:1167-1172.
37. Shankar TN, Shantha NV, Ramesh HP, Murthy IA, Murthy VS. Toxicity studies on turmeric (Curcuma longa): Acute toxicity studies in rats, guinea pigs and monkeys. Ind J Exp Biol 1980;18:73-75.
38. Skrzypczak-Jankun E, McCabe NP, Selman SH, Jankun J. Curcumin inhibits lipoxygenase by binding to its central cavity: Theoretical and X-ray evidence. Int J Mol Med 2000;6:521-526.
39. Srimal RC, Dhawan, N. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 1973;25:447-452.
40. Vijayalaxmi. Genetic effects of turmeric and curcumin in mice and rats. Mutat Res 1980;79:125-132.
41. White LB, Foster S. The Herbal Drugstore. Emaus, PA: Rodale Inc., 2000.
42. Xu YX, Pindolia KR, Janakiraman N, Chapman RA, Gautam SC. Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells. Hematopathol Mol Hematol 1997-1998;11:49-62.
43. Xu YX, Pindolia KR, Janakiraman N, Noth CJ, Chapman RA, Gautam SC. Curcumin, a compound with anti-inflammatory and anti-oxidant properties, downregulates chemokine expression in bone marrow stromal cells. Exp Hematol 1997;25:413-422.
44. Yamamoto H, Hanada K, Kawasaki K, Nishijima M. Inhibitory effect of curcumin on mammalian Phospholipase D activity. FEBS Lett 1997;417:196-198.
45. Young-Joon S. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat Res 1999;428:305-327.
46. Zhang F, Altorki NK, Mestre JR, Subbaramaiah K, Dannenberg AJ. Curcumin inhibits cyclooxygenase-2 transcription in bile acid-and phorbol ester treated human gastrointestinal epithelial cells. Carcinogenesis 1999;20: 445-451.